Dermatology and HIV/AIDS in Africa

Hu, Jenny; McKoy, Karen; Papier, Art; Klaus, Sidney N.; Ryan, Terence J.; Grossman, Henning; Masenga, Elisante J.; Sethi, Aisha; Craft, Noah

doi:10.4103/0974-777x.83535

Cited by 19 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The skin problems here are further compounded by the high prevalence of HIV which commonly causes skin lesions [ 7 ]. It was reported that approximately 90% of people living with HIV have skin changes and symptoms during the course of their disease [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Oninla

2014

AIDS Research and Treatment

View full text Add to dashboard Cite

Skin diseases are indicators of HIV/AIDS which correlates with WHO clinical stages. In resource limited environment where CD4 count is not readily available, they can be used in assessing HIV patients. The study aims to determine the mucocutaneous manifestations in HIV positive patients and their correlation with WHO clinical stages. A prospective cross-sectional study of mucocutaneous conditions was done among 215 newly diagnosed HIV patients from June 2008 to May 2012 at adult ART clinic, Wesley Guild Hospital Unit, OAU Teaching Hospitals Complex, Ilesha, Osun State, Nigeria. There were 156 dermatoses with oral/oesophageal/vaginal candidiasis (41.1%), PPE (24.4%), dermatophytic infections (8.9%), and herpes zoster (3.8%) as the most common dermatoses. The proportions of dermatoses were 4.5%, 21.8%, 53.2%, and 20.5% in stages 1–4, respectively. A significant relationship (using Pearson's Chi square with P value <0.05) was obtained between dermatoses and WHO clinical stages. Pearson's correlation coefficient showed a positive correlation between the number of dermatoses and the WHO clinical stages. Dermatoses can therefore serve as diagnostic and prognostic markers in resource limited settings to initiate HAART in clinical stages 3 and 4.

show abstract

Section: Introductionmentioning

confidence: 99%

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Oninla

2014

AIDS Research and Treatment

View full text Add to dashboard Cite

show abstract

“…In Nigeria, for example, it is estimated that in 2015 that 80 formally trained dermatologists served the nation’s population of 182 million (58,59). The Regional Dermatology Training Center in Tanzania was established in 1992 to provide dermatologic training for nurses in the Sub-Saharan region (60). Toby Maurer of University of California, San Francisco is also working to establish a dermatology residency training program in Uganda and Kenya.…”

Section: Improving Quality Of Care Through Innovationmentioning

confidence: 99%

Global Burden of Skin Disease: Inequities and Innovations

et al. 2017

View full text Add to dashboard Cite

Purpose of Review We review the current understanding of the burden of dermatological disease through the lens of the Global Burden of Disease project, evaluate the impact of skin disease on quality of life in a global context, explore socioeconomic implications, and finally summarize interventions towards improving quality of dermatologic care in resource-poor settings. Recent Findings The Global Burden of Disease project has shown that skin diseases continue to be the 4th leading cause of nonfatal disease burden world-wide. However, research efforts and funding do not match with the relative disability of skin diseases. International and national efforts, such as the WHO List of Essential Medicines, are critical towards reducing the socioeconomic burden of skin diseases and increasing access to care. Recent innovations such as teledermatology, point-of-care diagnostic tools, and task-shifting help to provide dermatological care to underserved regions in a cost-effective manner. Summary Skin diseases cause significant non-fatal disability worldwide, especially in resource-poor regions. Greater impetus to study the burden of skin disease in low resource settings and policy efforts towards delivering high quality care are essential in improving the burden of skin diseases.

show abstract

“…They can also be a sign of an underlying medical condition that might be life-threatening, such as HIV/AIDS. In view of the HIV/AIDS epidemic, the importance of dermatology cannot be underestimated, as 90% of HIV/AIDS patients develop a skin problem (see Table 1 ) during the course of their illness, and often initially present with a skin condition [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

The Development of a Mobile Application to Support Peripheral Health Workers to Diagnose and Treat People with Skin Diseases in Resource-Poor Settings

et al. 2018

View full text Add to dashboard Cite

The high prevalence of skin diseases in resource-poor settings, where health workers with sufficient knowledge of skin diseases are scarce, calls for innovative measures. Timely diagnosis and treatment of skin diseases, especially neglected tropical diseases (NTDs) that manifest with skin lesions, such as leprosy, is crucial to prevent disabilities as well as psychological and socioeconomic problems. Innovative technological methods like telemedicine and mobile health (mHealth) can help to bridge the gap between the burden of skin diseases and the lack of capable staff in resource-poor settings by bringing essential health services from central level closer to peripheral levels. Netherlands Leprosy Relief (NLR) has developed a mobile phone application called the ‘SkinApp’, which aims to support peripheral health workers to recognize the early signs and symptoms of skin diseases, including skin NTDs, and to start treatment promptly or refer for more advanced diagnostic testing or disease management when needed. Further research is needed to determine how greatly mHealth in general and the SkinApp in particular can contribute to improved health outcomes, efficiency, and cost-effectiveness.

show abstract

Dermatology and HIV/AIDS in Africa

Cited by 19 publications

References 24 publications

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Global Burden of Skin Disease: Inequities and Innovations

The Development of a Mobile Application to Support Peripheral Health Workers to Diagnose and Treat People with Skin Diseases in Resource-Poor Settings

Contact Info

Product

Resources

About